You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

fludarabine

( flu-DA-ra-been )
Funding:
New Drug Funding Program
  • Fludarabine - Indolent Lymphoma
ODB Limited Use
  • fludarabine - For the first-line treatment of CLL in combination with rituximab (tablets; with or without cyclophosphamide)
  • fludarabine - For second-line therapy of patients with CLL who have failed or are intolerant to chlorambucil (tablets)
Other Name(s): Fludara®
Appearance: Clear solution mixed into larger bags of fluids. Also available as tablets.

You might also be interested in